AbbVie
ABBV
#29
Rank
HK$3.833 T
Marketcap
HK$2,170
Share price
1.49%
Change (1 day)
20.85%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of June 2026 : -HK$46.21 Billion

According to AbbVie's latest financial reports the company has -HK$46.21 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-HK$25.12 Billion-196.17%
2024-12-31$HK$26.11 B-67.84%
2023-12-31$HK$81.20 B-39.88%
2022-12-31$HK$135.06 B12.22%
2021-12-31$HK$120.36 B18.55%
2020-12-31$HK$101.53 B-259.53%
2019-12-31$-HK$63.65 Billion-3.77%
2018-12-31$-HK$66.14 Billion-266.09%
2017-12-31$HK$39.82 B10.77%
2016-12-31$HK$35.95 B17.57%
2015-12-31$HK$30.57 B126.3%
2014-12-31$HK$13.51 B-61.21%
2013-12-31$HK$34.83 B33.63%
2012-12-31$HK$26.06 B-71.87%
2011-12-31$HK$92.67 B-24.16%
2010-12-31$HK$122.20 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
HK$670.87 B-1,551.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$265.85 B-675.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$91.71 B-298.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$147.90 B-420.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$92.15 B-299.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$175.14 B-479.06%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$395.26 B-955.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$178.60 B-486.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$28.98 B-162.73%๐Ÿ‡บ๐Ÿ‡ธ USA